Leelyn Smith’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Leelyn Smith’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,298	Closed	-$461K	–	159
2026 Q1	$461K	Buy	+2,298	New	+$475K	0.06%	120
2020 Q3	–	Sell	-1,814	Closed	-$304K	–	338
2020 Q2	$304K	Buy	+1,814	New	+$285K	0.13%	98

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Leelyn Smith's FBT Position: Q2 2026 in Review

Leelyn Smith sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 2,298 shares — an estimated $461K sold.

Leelyn Smith first reported a position in FBT in Q2 2020 and held it in 2 quarters. The position peaked at $461K in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Leelyn Smith reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
Leelyn Smith sold 2,298 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $461K.
Leelyn Smith first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2020 and held it in 2 quarters.
Leelyn Smith's First Trust NYSE Arca Biotechnology Index Fund position peaked at $461K in Q1 2026.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Leelyn Smith's 13F filing for Q2 2026, filed 24 Jul 2026.